Article
Targeted epigenetic repression of oncogenic transcription factors via CRISPR/dCas9 locus-specific silencing
2026-06-27
Abstract excerpt
Despite the revolutionary impact of genome engineering tools in medicine, the safe and effective intracellular delivery of CRISPR remains a major obstacle for clinical applications. Here, we implement precision molecular medicine and delivery strategies based on CRISPR/dCas9 systems adapted for epigenetic repression (dCas9-KRAB) to silence oncogenic drivers with high genomic selectivity. As proof-of-principle, we...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ae597921-8365-59aa-baf1-da1919086ff2
- DOI
- 10.64898/2026.06.27.734664
